Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Total Current Assets & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Total Current Assets

LCTX Total Current Assets

Latest reported$59.16Mperiod endingDec 31, 2025

LCTX FY Current Assets ($4.80M → $59.16M)

Annual total current assets

High-resolution chart · PNG

LCTX total current assets history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Total Current Assets — Annual fiscal periods (USD)
Period ending	Total Current Assets (USD)
Dec 31, 2025	59,157,000
Dec 31, 2024	50,997,000
Dec 31, 2023	38,441,000
Dec 31, 2022	60,000,000
Dec 31, 2021	111,549,000
Dec 31, 2020	43,999,000
Dec 31, 2019	57,519,000
Dec 31, 2018	36,358,000
Dec 31, 2017	42,623,000
Dec 31, 2016	25,649,000
Dec 31, 2015	47,237,000
Dec 31, 2014	32,404,557
Dec 31, 2013	7,949,970
Dec 31, 2012	7,179,479
Dec 31, 2011	24,955,374
Dec 31, 2010	35,572,678
Dec 31, 2009	12,366,012
Dec 31, 2008	108,874
Dec 31, 2007	141,646
Dec 31, 2006	618,692
Dec 31, 2005	1,931,630
Dec 31, 2004	1,492,987
Dec 31, 2003	1,007,049
Dec 31, 2002	1,382,118
Dec 31, 2001	1,762,179
Dec 31, 2000	1,440,986
Dec 31, 1999	5,400,091
Dec 31, 1998	2,600,000
Jun 30, 1998	6,600,000
Jun 30, 1996	2,900,000
Jun 30, 1995	3,500,000
Jun 30, 1994	5,800,000
Jun 30, 1993	3,500,000
Jun 30, 1992	4,800,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.